. SAHA and EGCG significantly reduce cellular viability in three triple-negative and one ER-positive breast cancer cell lines. All cell lines were treated for 72 h with SAHA and EGCG, alone or in combination. There were no significant changes in cellular viability in the MCF10A non-cancerous control cells with low single doses of SAHA or EGCG (A). ER-positive MCF-7 cells (B) and all three triple-negative cell lines (C-E) experienced a reduced viability with the combination of SAHA and EGCG. We chose to proceed with 3 M SAHA and 5 M EGCG. Error bars represent standard error of the mean (SEM);
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